go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

sanofi-aventis
Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 4035600
Fax: +353 1 4035687
Medical Information e-mail: IEmedinfo@sanofi-aventis.com
Summary of Product Characteristics last updated on medicines.ie: 14/05/2010
SPC Lasix 20mg and 40mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
Date of revision of text on the SPC:   01-May-2010
Legal Category:   Product subject to restricted prescription (C)

Free-text change information supplied by the pharmaceutical company
Addition of SJS & TEN to Section 4.8.
Updated on 22/03/2010 and displayed until 14/05/2010
Reasons for adding or updating:
  • Change to section 6.4 - Special precautions for storage
Date of revision of text on the SPC:   01-Mar-2010
Legal Category:   Product subject to restricted prescription (C)

Free-text change information supplied by the pharmaceutical company
Lasix 40mg: Update Section 6.4
Store below 30ºC. Store in the original package.  Protect from light.
Updated on 22/07/2009 and displayed until 22/03/2010
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Date of revision of text on the SPC:   01-Jul-2009
Legal Category:   Product subject to restricted prescription (C)

Free-text change information supplied by the pharmaceutical company
Update section 4.4 and 4.5 to include warning on concurrent use with risperidone.
Updated on 24/07/2008 and displayed until 22/07/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 17/08/2007 and displayed until 24/07/2008
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
Date of revision of text on the SPC:   07/2007
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company
Update
Section 4.4 - statement on use in patients with partial obstruction of urinary output
Seciton 4.8 - additional undesirable effects and reformatting of section
Updated on 11/05/2007 and displayed until 17/08/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 08/01/2007 and displayed until 11/05/2007
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Furosemide